Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria

Sun Yat-sen University · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
hepatocellularcarcinomapd
hepatocellular carcinoma, lenvatinib, pd-1 antibody, tace, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 856595
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.